Niagen Bioscience (NAGE) Financial Statements & Analysis

Niagen Bioscience (NAGE) Income Statement

Niagen Bioscience reported revenue of $129.42M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 29.9% from $99.60M a year earlier. Net income was $17.38M, up 103.3% year over year, a net margin of 13.4%. Gross margin was 64.3% and operating margin 11.0%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $29.79M, down 4.3% from the same quarter a year earlier.

Niagen Bioscience Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Niagen Bioscience, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	129.42	99.60	83.57	72.05	67.45	59.26	46.29	31.56	21.20
Cost of Revenue	46.23	38.01	32.79	29.25	25.96	23.98	20.52	15.50	10.72
Gross Profit	83.19	61.59	50.78	42.80	41.49	35.27	25.77	16.06	10.48
Operating Expenses
Research & Development	6.33	6.02	4.96	4.83	3.83	3.42	4.42	5.48	4.01
Selling, General & Administrative	62.56	47.84	51.42	56.60	64.73	51.71	52.52	43.67	22.10
Operating Expenses	68.89	53.86	56.38	61.43	68.56	55.13	57.07	49.23	26.85
Operating Income	14.30	7.73	-5.60	-18.63	-27.07	-19.85	-31.30	-33.17	-16.38
Other Income/Expense
Interest Income	2.13	1.13	0.66	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	-0.06	-0.07	0.85	0.08	0.15
Other Income/Expense	1.77	2.26	0.66	2.09	-0.06	-0.07	-0.85	-0.14	-0.15
Income
Income Before Tax	18.19	8.86	-4.94	-16.54	-27.13	-19.93	-32.15	-33.32	-16.53
Income Tax Expense	0.81	0.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	17.38	8.55	-4.94	-16.54	-27.13	-19.93	-32.15	-33.32	-11.38
Net Income - Continuous Operations	17.38	8.55	-4.94	-16.54	-27.13	-19.93	-32.15	-33.32	-11.38
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	15.75	9.21	-4.57	-16.74	-25.45	-18.74	-29.78	-32.33	-15.66
EBIT	14.30	7.73	-5.60	-18.63	-27.07	-19.85	-	-	-
Depreciation & Amortization	1.45	1.48	1.03	1.88	1.63	1.11	1.52	0.84	0.72
Earnings Per Share
Basic EPS	-	-	-	-	-	-	-1.00	-1.00	-
Diluted EPS	-	-	-	-	-	-	-1.00	-1.00	-
Basic Shares Outstanding	79.18	75.93	74.99	69.73	67.19	61.07	57.06	55.01	44.60
Diluted Shares Outstanding	85.44	78.13	74.99	69.73	67.19	61.07	57.06	55.01	44.60

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Niagen Bioscience Financial Statements

What was Niagen Bioscience's revenue in fiscal 2025?

Niagen Bioscience reported revenue of $129.42M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 29.9% from $99.60M a year earlier.

Is Niagen Bioscience profitable?

Yes. Niagen Bioscience earned net income of $17.38M in fiscal 2025, a net margin of 13.4%. In fiscal 2024 it earned $8.55M.

What is Niagen Bioscience's operating margin?

Niagen Bioscience's operating income was $14.30M on revenue of $129.42M in fiscal 2025, an operating margin of 11.0%, compared with 7.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition